Riskpilot← Back to searchSign inGet full accessONCOINVENT ASA
ASAActiveOrg 992219688Gullhaugveien 7, 0484 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20085 employeeswww.oncoinvent.com
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2024
NOK 0
5 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK 0 | — |
| Net profit | NOK 0 | — |
| Total assets | — | — |
| Equity | — | — |
| Employees | 5 | — |
Legal name
ONCOINVENT ASA
Org number
992219688
Legal form
Allmennaksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
31. januar 2008
Share capital
NOK 1 119 603
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikle, markedsføre og selge medisinske produkter og utstyr samt det som står i forbindelse med dette.
Address
Gullhaugveien 7, 0484 Oslo
Phone
+4755961159
Email
post@bergenbio.com
Website
www.oncoinvent.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 0 | 0 | 0 | 0 | 0 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 0 | 0 | 0 | 0 |
| Net financials | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 0 | 0 | 0 | 0 | 0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | — | — | — | — |
| Equity | — | — | — | — | — |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 | 0 | 0 |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20202024
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20202024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
ØS Chief Executive Officer | Chief Executive Officer | 2025 |
OH Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
RS Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
MO Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
RS Chief Executive Officer | Chief Executive Officer | 2010 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (11) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Chairman | 2022 | |
| Board of Directors | 2026 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Chairman | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 23.05% | 23.05% | 2024 | |
| Company | 5.81% | 5.81% | 2024 | |
| Individual | 5.06% | 5.06% | 2022 | |
| Company | 2.14% | 2.14% | 2024 | |
| Individual | 1.95% | 1.95% | 2022 | |
| Company | 1.76% | 1.76% | 2024 | |
| Company | 1.7% | 1.7% | 2022 | |
Nordnet Bank Ab | Company | 1.69% | 1.69% | 2024 |
J.P. Morgan Se | Company | 1.28% | 1.28% | 2024 |
| Company | 1.03% | 1.03% | 2024 | |
| Company | 1.02% | 1.02% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
NÆRINGS- OG FISKERIDEPARTEMENTET
ONCOINVENT ASA Board members of ONCOINVENT ASA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rune Skeie | Chief Executive Officer | 0 companies |
| Martin Olin | Chief Executive Officer | 0 companies |
| Richard Stuart Godfrey | Chief Executive Officer | 0 companies |
| Øystein Soug | Chief Executive Officer | 0 companies |
| Olav Hellebø | Chief Executive Officer | 0 companies |
| Sally Louise Bennett | Board of Directors | 0 companies |
| Stener Kvinnsland | Board of Directors | 0 companies |
| Debra Stephanie Barker | Board of Directors | 0 companies |
| Hilde Hermansen Steineger | Board of Directors | 0 companies |
| Anne Cecilie Alvik | Board of Directors | 0 companies |
| Francois Claude Pierre Thomas | Board of Directors | 0 companies |
| Ingrid Helene Teigland Akay | Board of Directors | 0 companies |
| Johan Erik Häggblad | Board of Directors | 0 companies |
| Kari Grønås | Board of Directors | 0 companies |
| Charles Gillies O Bryan-Tear | Chairman | 0 companies |
| Anders Lennart Tullgren | Chairman | 0 companies |
| Orlando Manuel Correia Monteiro De Oliveira | Board of Directors | 0 companies |
| David Colpman | Board of Directors | 0 companies |
| Sveinung Hole | Chairman | 0 companies |